[HTML][HTML] COVID-19 signalome: Potential therapeutic interventions

K Lundstrom, A Hromić-Jahjefendić, E Bilajac… - Cellular signalling, 2023 - Elsevier
The COVID-19 pandemic has triggered intensive research and development of drugs and
vaccines against SARS-CoV-2 during the last two years. The major success was especially …

[HTML][HTML] COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity

K Lundstrom, A Hromić-Jahjefendić, E Bilajac… - Cellular …, 2023 - Elsevier
The COVID-19 pandemic has been the focus of research the past two years. The major
breakthrough was made by discovering pathways related to SARS-CoV-2 infection through …

[HTML][HTML] SARS-CoV-2 signaling pathway map: A functional landscape of molecular mechanisms in COVID-19

DAB Rex, S Dagamajalu, RK Kandasamy… - Journal of Cell …, 2021 - Springer
Abstract Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). COVID-19 has been declared a pandemic by WHO. The …

[HTML][HTML] Cellular and molecular pathways of COVID-19 and potential points of therapeutic intervention

JP Hussman - Frontiers in pharmacology, 2020 - frontiersin.org
With the objective of linking early findings relating to the novel SARS-CoV-2 coronavirus
with potentially informative findings from prior research literature and to promote …

Understanding individual SARS-CoV-2 proteins for targeted drug development against COVID-19

J van de Leemput, Z Han - Molecular and cellular biology, 2021 - Taylor & Francis
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the COVID-
19 pandemic, responsible for millions of deaths globally. Even with effective vaccines, SARS …

[PDF][PDF] From SARS-CoV to SARS-CoV2: a potential guide to better understanding of pathophysiology of the disease and potential therapeutic modality.

PA Pashaki, MH Roudkenar, F Rahim… - European Review for …, 2020 - europeanreview.org
Currently, the outbreak and spread of coronavirus disease 2019 (COVID-19) caused by
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), are increasing …

[HTML][HTML] Spiking pandemic potential: structural and immunological aspects of SARS-CoV-2

YT Wang, S Landeras-Bueno, LE Hsieh, Y Terada… - Trends in …, 2020 - cell.com
SARS-Coronavirus-2 (SARS-CoV-2) causes Coronavirus disease 2019 (COVID-19), an
infectious respiratory disease causing thousands of deaths and overwhelming public health …

Analysis of the SARS-CoV-2-host protein interaction network reveals new biology and drug candidates: focus on the spike surface glycoprotein and RNA polymerase

E Sokullu, M Pinard, MS Gauthier… - Expert Opinion on Drug …, 2021 - Taylor & Francis
Introduction: The COVID-19 pandemic originated from the emergence of anovel coronavirus,
SARS-CoV-2, which has been intensively studied since its discovery in order to generate the …

[HTML][HTML] Druggable targets and therapeutic development for COVID-19

X Duan, LA Lacko, S Chen - Frontiers in Chemistry, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen causing
coronavirus disease 2019 (COVID-19), has led to a worldwide social and economic crisis …

A review on novel drug targets and future directions for COVID-19 treatment

YT Wondmkun, OA Mohammed - Biologics: Targets and Therapy, 2020 - Taylor & Francis
Severe acute respiratory syndrome coronavirus-2 causes coronavirus disease-19 (COVID-
19) that spreads quickly in the world. Considering the impact of this pandemic, researchers …